Igal Sudman

Igal Sudman Recent News

Ayurcann Slight Revenue Increase In Q3 Fiscal 2022 Of 7.69% YoY
Ayurcann Holdings Corp. (OTCQB: AYURF) (CSE:AYUR) (FSE:3ZQ0) Q3 fiscal 2022 revenue was CA$2.8 million ($2.19 million), compared to CA$2.6 million in Q3 2021. Q3 Fiscal 2022 Highlights
Cannabis Extraction Co. Ayurcann Shares Slightly Up On Record Sales, 106% YoY Revenue Growth
Cannabis extraction company, Ayurcann Holdings Corp. (CSE:AYUR) (OTCQB:AYURF) (FSE:3ZQ0) reported its financial and operating results for its second quarter ending December 31, 2021. All figures reported are in Canadian dollars. Q2 Financial Summary
Ayurcann Launches Fuego THC Vapes In Alberta And Symbol Change On OTCQB Market
Canadian cannabis extraction company Ayurcann Holdings Corp. (CSE:AYUR) (OTCQB:AYURF) (FSE:3ZQ0) announced the launch of their high potency THC branded "Fuego" vapes into Alberta. Based in Toronto, the company said that Alberta is the 5th Canadian province it has entered in the last four months.
Cannabis Extraction Company Ayurcann Rolls Out High Potency THC Fuego Vapes In Ontario
Canadian cannabis extraction company Ayurcann Holdings Corp. (CSE: AYUR) (OTCQB: CDCLF) (FSE:3ZQ0) is launching its high potency THC branded “Fuego” vapes in Ontario.
Ayurcann Holdings Corp. Reports Third Consecutive Quarter of Positive Operating Income
Ayurcann Holdings Corp. (CSE: AYUR) (FSE: 3ZQ0) a Toronto-based cannabis extraction company specializing in processing and manufacturing cannabis products, reported its financial and operating results for the three months ended September 30, 2021, in a press release on Monday, Nov. 29. Highlights For The First Quarter Ended September 30, 2021
Ayurcann Revenue: Ten-Fold Increase In 2021, Reaches $7.6M, Net Loss Drops 33%
Canadian cannabis extraction company Ayurcann Holdings Corp. (CSE: AYUR) (FSE: 3ZQ0) reported its financial and operating results on Friday for the year ending June 30, 2021, reporting 1,149% year-over-year in revenue to CA$7.63 million ($6.16 million).
Ayurcann To Manufacture And Distribute Israel's Innocan Pharma's CBD Topicals In Canada
Cannabis-focused extraction company Ayurcann Holdings Corp. (CSE: AYUR) has partnered with Israeli pharmaceutical tech company Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) to produce its CBD topical products.
Cannabis Extraction Co. Ayurcann Holdings To Debut On OTCQB
Canadian cannabis extraction company Ayurcann Holdings Corp. (CSE: AYUR) is poised to list its shares on the OTCQB, a U.S. market operated by OTC Markets Group Inc. in New York.
Cannabis Movers & Shakers: Valens, Ayurcann, SpeakEasy, General Cannabis
Valens Shakes Up Leadership Team The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) has recently appointed Sunil Gandhi as its chief financial officer and Adam Shea as chief commercial officer.